J Frontier Co

J Frontier Co CROIC

The Cash Return on Invested Capital (CROIC) of J Frontier Co (2934.T) as of Oct 27, 2026 is 6.05 %. In the previous year, Cash Return on Invested Capital (CROIC) was 7.78 % — a change of -22.25% (lower).

CROIC

6.05 %

YoY

-22.25%

Last updated:

Cash Return on Invested Capital (CROIC) of J Frontier Co is 2026 6.05 % . Cash Return on Invested Capital (CROIC) of J Frontier Co was 2025 7.78 % . It decreases by -22.25% lower compared to the previous year.

The J Frontier Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
-3.29 JPY
Jan 1, 2020
21.07 JPY
Jan 1, 2021
61.36 JPY
Jan 1, 2022
-8.06 JPY
Jan 1, 2023
-41.95 JPY
Jan 1, 2024
-24.51 JPY
Jan 1, 2025
7.78 JPY
Jan 1, 2026
6.05 JPY
The J Frontier Co CROIC history
YEARCROICYoY
6.05 %-22.25%
7.78 %-131.73%
-24.51 %-41.57%
-41.95 %+420.27%
-8.06 %-113.14%
61.36 %+191.19%
21.07 %-740.89%
-3.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

J Frontier Co Stock analysis

What does J Frontier Co do? J Frontier Co., Ltd. generates revenue through three business segments. The Healthcare Sales segment sells health foods and cosmetics, including the 328 selection series of fermented hydrogen, via mail-order. The Medical Care Sales segment operates dispensing pharmacies and offers mail-order services for ethical drugs, alongside the Why Pure series and Chinese herbs. The Health Care Marketing segment provides advertising agency services, sales promotion support, and wholesale of in-house products for healthcare brands. The company's primary customers are consumers purchasing health foods, cosmetics, and pharmaceuticals through mail-order channels. Pharmacies and healthcare product distributors also buy services from the Health Care Marketing segment for advertising and sales support. The firm's brands include 328 selection, Why Pure, and Chinese herbs, which are sold directly or through marketing partnerships. J Frontier's revenue streams are driven by direct sales of its branded products, mail-order distribution of health and medical goods, and marketing services for healthcare brands. The company targets health-conscious consumers and healthcare businesses seeking promotional support and product distribution. J Frontier Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about J Frontier Co stock

Cash Return on Invested Capital (CROIC) of J Frontier Co is 6.05 % in 2026.

Cash Return on Invested Capital (CROIC) of J Frontier Co changed from 7.78 % to 6.05 %, representing a -22.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) J Frontier Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s J Frontier Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — J Frontier Co

All Key Metrics — J Frontier Co